DPCR and qPCR Market – Survey on Health Impacts 2025 | Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, TaKARA BIO, Agilent Technologies

The report provides a detailed overview on the Global DPCR and qPCR Market with overview and forecast of the global DPCR and qPCR Market based on tools, application, and geography. It also provides market size and forecast till 2025 for overall DPCR and qPCR Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America.

Global Analysis and Forecasts by Technology (Digital PCR (dPCR) and Quantitative PCR (qPCR)); Product (Reagents & Consumables, Software and Services and Instruments); Application (Clinical Application, Research Application, and Forensic Application) and Geography

MARKET INTRODUCTION

According to a new market research study titled ‘dPCR and qPCR Market to 2025 – Global Analysis and Forecasts by technology, product and application. The global dPCR and qPCR market is estimated to account for US$ 6,371.6 Mn by 2025 as compared to US$ 3,255.5 Mn in 2017, growing at a CAGR of 9.1% during the forecast period from 2018 to 2025. The report highlights the trends prevalent in the global dPCR and qPCR market and the factors driving the market along with those fact as restraint to its growth.

Get Sample Copy of This Report: http://bit.ly/2EzgEC2

Key Benefits-
• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global DPCR and qPCR Market
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

MARKET PLAYERS

Key industry players operating in the field of dPCR and qPCR across the globe include Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies, Inc., bioMérieux SA, Danaher, Fluidigm Corporation.

MARKET SCOPE

The growth of the dPCR and qPCR market is expected rise due to the trending technologies used for the dPCR and qPCR. The innovative technologies used for dPCR and qPCR have brought promises of unexpected changes in the healthcare industry. dPCR and qPCR is a PCR technology which has evolved over the years from thermostable polymerases, development of automated thermocyclers to latest digital PCR (d-PCR) methodologies. However the basic principle of denature, anneal, extend remains the same. qPCR has spawned the second generation that allows analysis and diagnosis with reduced risk of contamination and is considered as ‘gold standard’. dPCR amplifies the target DNA molecule and quantifies directly without external calibrator. This has been used extensively for studying variations in gene sequences. Many biotechnology, pharmaceutical companies and research organizations are outsourcing their research and development activities in order to reduce their operation cost. This increases the demand for dPCR and qPCR technologies in the market. With these numerous advantages the market is expected to witness rapid growth.

Don’t miss out on business opportunities in DPCR and qPCR Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

MARKET SEGMENTATION

The application segment of the dPCR and qPCR market is classified into clinical applications, research applications, and forensic applications. In 2017, the research application segment held the largest share of 49.3% of the market, by application. Wide applications of qPCR and dPCR in stem cell research, oncology & genetic disease research and also the commercialization of new dPCR instruments such as droplet dPCR, QuantStudio 3D dPCR, and BioMark HD dPCR system are expected to boost market growth. The overall research application segment market was valued at US$ 1,606.3 Mn in 2017 and is anticipated to grow significantly in the forecast period. Likewise, the clinical application segment is expected to be the fastest growing application segment for the dPCR and qPCR market. Clinical application segment is further segmented into pathology testing, oncology testing and blood screening testing.

REGIONAL FRAMEWORK

North America is expected to contribute to the largest share in the dPCR and qPCR Market in the coming years, owing to rising investments made in R&D activities for the discovery as well as the development of novel drugs. Also, Asia Pacific is anticipated to witness steady growth during the forecast period, due to increasing clinical trials in the region.

The report segments the global dPCR and qPCR market as follows:
Global dPCR and qPCR Market – By Technology
• Digital PCR (dPCR)
• Quantitative PCR (qPCR)

Global dPCR and qPCR Market – By Product
• Reagents & Consumables
• Instruments
• Software and Services

Global dPCR and qPCR Market – By Application
• Clinical Application
o Pathogen Testing
o Oncology Testing
o Blood Screening Testing
• Research Application
• Forensic Application

Global dPCR and qPCR Market – By Geography
o North America
 U.S.
 Canada
 Mexico
o Europe
 UK
 Germany
 France
o Asia Pacific (APAC)
 Japan
 China
 India
o Middle East & Africa (MEA)
 South Africa
 Saudi Arabia
 UAE
o South & Central America (SCAM)
 Brazil

Direct Purchase a Copy of this Report at: http://bit.ly/2XrDFyc

About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Home: https://www.theinsightpartners.com

This release was published on openPR.